Results 181 to 190 of about 73,633 (314)

Use of Angiotensin (AII) antagonist losartan in patient treated with DSC LDL-apheresis. [PDF]

, 1999
P. Maxia, Stefano Pintus, A. Bianco, Paolo Pintus, A. Sanna   +4 more
openalex   +1 more source

Evaluation of Chronic Losartan Treatment Effect on Cardiac Chronotropic Dysfunction in Biliary Cirrhotic Rats

Acta Medica Iranica, 2018
Cirrhosis is associated with cardiac chronotropic and inotropic dysfunction which is known as cirrhotic cardiomyopathy. Cardiac responsiveness to adrenergic stimulation is impaired in cirrhosis. Moreover, there is vagal nerve dysfunction which is related
Farahnaz Jazaeri, Razieh Afsharmoghaddam, Alireza Abdollahi, Giti Ghamami, Ahmad Reza Dehpour   +4 more
doaj  

E039 Extended therapeutic control in essential hypertension: Comparison of the impact of missed doses of tasosartan and losartan [PDF]

, 1998
Yves Lacourcière
openalex   +1 more source

A promise to save 100,000 trauma patients.

, 2013
Horton, Richard, Krug, Etienne, Mersch, Jeannot, Piot, Peter, Roberts, Ian, Shakur, Haleema   +5 more
core   +1 more source

Management of Proteinuria in Dogs and Cats with Chronic Kidney Disease [PDF]

, 2016
Atkins, Bakris, Bianchi, Bomback, Brown, Brown, Brown, Brown, Bugbee, Christ, Finco, Grauer, Grauer, Horita, Jacob, Jenkins, Jepson, Jepson, Jonathan Elliott, King, King, Laverman, Lees, Lefebvre, LeVine, Linas, Littman, Maack, McAlister, Mizutani, Nabity, Nakamura, Pollock, Pressler, Ryan, Schjoedt, Schneider, Segev, Segev, Sent, Shelly L. Vaden, Singh, Syme, Tenhundfeld, Toblli, Vaden, Wehner   +46 more
core   +1 more source

Effect of losartan on human platelet activation [PDF]

, 1999
Juan Guerra
openalex   +1 more source

D14 Experience with losartan in 3 categories of hypertensive patients [PDF]

, 1997
Myles Brown
openalex   +1 more source

Pharmacological characteristics and clinical application of losartan, an orally active AT1 angiotensin II receptor antagonist.

, 1999
Hisashi Ohta, Satomi Tanaka, Jun Suzuki, Fumihiko Ikemoto, Masaru Nishikibe   +4 more
openalex   +2 more sources

Losartan as a mechanotherapeutic adjuvant: Remodeling the breast tumor microenvironment to improve treatment efficacy. [PDF]

PLoS One
Dwairy M, Yehya A, Mohammad FM, Alzoubi H.   +3 more
europepmc   +1 more source

The antiarrhythmic potential of angiotensin II antagonism: experience with losartan [PDF]

, 2000
Haralambos Gavras, Haralambos Gavras
openalex   +1 more source